Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGIC: Sugammadex Immunomodulation in Hip Surgery
NCT05723406Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2023
- Primary completion
- Nov 2023
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sugammadex in immune dysregulation, sponsored by Radboud University Medical Center. Started Mar 2023; status: completed.
02
Drugs
Sugammadex
03
Conditions
immune dysregulation
Beyond the preview
Go deeper on NCT05723406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05723406.